CA2186752A1 - Traitement a l'aide de medicaments de sites pathologiques en profondeur a l'interieur du corps - Google Patents

Traitement a l'aide de medicaments de sites pathologiques en profondeur a l'interieur du corps

Info

Publication number
CA2186752A1
CA2186752A1 CA002186752A CA2186752A CA2186752A1 CA 2186752 A1 CA2186752 A1 CA 2186752A1 CA 002186752 A CA002186752 A CA 002186752A CA 2186752 A CA2186752 A CA 2186752A CA 2186752 A1 CA2186752 A1 CA 2186752A1
Authority
CA
Canada
Prior art keywords
drug treatment
diseased sites
sites deep
site
deep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002186752A
Other languages
English (en)
Other versions
CA2186752C (fr
Inventor
Peter M. Nicholas
Ronald A. Sahatjian
James J. Barry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/219,108 external-priority patent/US5588962A/en
Application filed by Individual filed Critical Individual
Publication of CA2186752A1 publication Critical patent/CA2186752A1/fr
Application granted granted Critical
Publication of CA2186752C publication Critical patent/CA2186752C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/104—Balloon catheters used for angioplasty
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1002—Intraluminal radiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/109—Balloon catheters with special features or adapted for special applications having balloons for removing solid matters, e.g. by grasping or scraping plaque, thrombus or other matters that obstruct the flow

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002186752A 1994-03-29 1995-03-29 Traitement a l'aide de medicaments de sites pathologiques en profondeur a l'interieur du corps Expired - Fee Related CA2186752C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/219,108 1994-03-29
US08/219,108 US5588962A (en) 1994-03-29 1994-03-29 Drug treatment of diseased sites deep within the body
PCT/US1995/003872 WO1995026214A1 (fr) 1994-03-29 1995-03-29 Traitement a l'aide de medicaments de sites pathologiques en profondeur a l'interieur du corps

Publications (2)

Publication Number Publication Date
CA2186752A1 true CA2186752A1 (fr) 1995-10-05
CA2186752C CA2186752C (fr) 2007-06-26

Family

ID=38278935

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002186752A Expired - Fee Related CA2186752C (fr) 1994-03-29 1995-03-29 Traitement a l'aide de medicaments de sites pathologiques en profondeur a l'interieur du corps

Country Status (1)

Country Link
CA (1) CA2186752C (fr)

Also Published As

Publication number Publication date
CA2186752C (fr) 2007-06-26

Similar Documents

Publication Publication Date Title
DE60026538D1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
EP0933995B8 (fr) Methode de traitement des lesions endotheliales
EP0504881A3 (en) Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same
EP0962225A3 (fr) Utilisation de la phentolamine pour la fabrication d'un médicament pour le traitement du dysfonctionnement érectile
WO2002056912A3 (fr) Methode de traitement du cancer
AU7476894A (en) Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
WO1998010767A3 (fr) Utilisation de derives de la quinazoline pour la fabrication d'un medicament destine au traitement de troubles cutanes hyperproliferatifs
WO2001012122A3 (fr) Procede et systeme de traitement de l'arret cardiaque par hypothermie
CA2181742A1 (fr) Reduction de l'irritation de la peau pendant l'administration de medicament par electrotransport
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
CA2186493A1 (fr) Catheter d'apport de medicament par dilatation
WO2003024387A3 (fr) Methode et composition pharmaceutique destinees au traitement d'inflammations
UA32429C2 (uk) Засіб для лікування нетримання сечі
WO2001028491A3 (fr) Procede et composition utilises afin de traiter les affections dermatologiques
CA2373794A1 (fr) Compositions et utilisation d'et743 pour le traitement du cancer
IE790756L (en) Cerebral therapeutic agent
AU693833B2 (en) Products containing G-CSF and TNF binding protein
EP0355811A3 (fr) Agent de contrôle des formations de thrombus
CA2221900A1 (fr) Utilisation de chlorure de trospium et systeme a deux constituants pour ce compose
EP1304108A3 (fr) Compositions pour traiter l'arythmie et procédés de traitement
AU3401093A (en) Therapeutic agent for threatened abortion
WO2000006136A3 (fr) METHODE PERMETTANT DE TRAITER LE CANCER CHEZ DES PATIENTS PRESENTANT UNE DEFICIENCE DU SUPPRESSEUR DE TUMEUR p53
WO2001041771A3 (fr) Systeme transdermique contenant de l'acide acetylsalicylique pour le traitement de la migraine
EP1512413A3 (fr) Composition pharmaceutique contenant de la 4-amino-quinazoline et un autre agent antinéoplastique, pour le traitement du cancer.
CA2306772A1 (fr) Utilisation d'alcools aliphatiques c18 a c26 pour preparer un medicament destine a traiter les dermatites hyperproliferantes

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed